Table 1.

Summary of cases including clinical, imaging, and clinicopathological diagnosis

	Case 1	Case 2	Case 3	Controls
Age at symptom onset (y)	62	58–60	81	N/A
Age at death (y)	68	67	84	72.7SD 17.6
AV-45 findings	Positive for amyloid	Positive for amyloid	Positive for amyloid	N/A
AV-133 findings	Bilateral caudate and putamen dopaminergic depletion	Normal	Dopaminergic depletion in center putamen and 3/5 readers noted a decrease in right putamen as well	N/A
Clinical diagnosis at PET imaging	DLB	AD	DLB	N/A
Clinicopathological diagnosis	DLB and AD	DLB and AD	MSA and AD	Cognitively normal
Time between symptoms and imaging	5 y	5 y	3 y	N/A
Time between PET imaging and death	22 mo	30 mo	1–2 wk	N/A
Postmortem interval	3.0 h	3.1 h	2.5 h	4.0 h SD 0.8
NIA-AA ADNC	High ADNC	Intermediate ADNC	Intermediate ADNC	Not AD (1) Low AD (2)
Lewy body stage	Neocortical	Neocortical	N/A (MSA)	All Stage 0

NIA-AA ADNC, National Institute on Aging-Alzheimer’s Association Alzheimer’s Disease Neuropathological Change Level; Lewy body stage, Unified Staging System for Lewy Body Disorders stage level; N/A, not applicable.